Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China
- PMID: 32530494
- PMCID: PMC7307018
- DOI: 10.1002/jmv.26168
Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China
Abstract
The outbreak of SARS-CoV-2 has become a pandemic with significant mortality. Published studies described clinical characteristics of the disease contain small cohorts from individual centers or larger series consisting of mixed series from multiple different hospitals. We report here analyses of mortality and disease severity among 402 patients from a single hospital. The cohort includes 297 patients with confirmed and 105 with clinical diagnosis. The latter group consists of cases with inconclusive nucleic acid test but meeting the criteria for clinical diagnosis. Data are compared between sexes and among different age groups. The overall case fatality is 5.2%. However, age at 70 years or older is associated with a significantly higher mortality (17.8%) and higher rate of severe and critical illness (57.5%). Case fatality is 8% in patients 50 years of age or older, and 1.2% in those younger than 50 years. In addition, case fatality is 7.6% in male patients, as opposed to 2.9% in females, demonstrating a clear sex difference.
Keywords: COVID-19; SARS-CoV-2; coronavirus; diagnosis; epidemiology; fatality; mortality.
© 2020 Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures
References
-
- Li J, Ye G, Chen L, Wang J, Li Y. Analysis of false‐negative results for 2019 novel coronavirus nucleic acid test and related countermeasures. Chin J Lab Med. 2020;43:E006.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
